on ABIVAX (EPA:ABVX)
Bank of America Corporation exceeds 5% of ABIVAX's capital
On May 28, 2026, Bank of America Corporation crossed the 5% threshold of ABIVAX's share capital and voting rights. Through its subsidiaries, it now holds 5,149,637 shares, representing 6.49% of the share capital and 6.31% of the voting rights. This increase resulted from additional share purchases on the market.
The main subsidiaries involved are Merrill Lynch International and BofA Securities, Inc. Numerous contracts, such as rights of use and call options, reinforce this position. In addition, complex financial instruments, such as swaps, are also used. These actions demonstrate Bank of America's growing interest in ABIVAX.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all ABIVAX news